In line with the observation, flow cytometry analysis detected a surge in CD8+ T cells after μGCTrp2 treatment in peripheral blood, lymph nodes, spleens, and tumor‐bearing lungs (Figure S13, Supporting Information). This evidence concerns the gene CD8A and neoplasm.